Dr Reddy’s Labs Gains After U.S. Unit Files NDA For Migraine Drug — Shares of the Hyderabad-based drug maker rose as much as 2.6 percent to Rs 2,135 after its U.S. subsidiary Promius Pharma filed for New Drug Application (NDA) for its migraine candidate.
Spread the love
Neal Bhai
Neal Bhai has been involved in the Bullion and Metals markets since 1998 – he has experience in many areas of the market from researching to trading and has worked in Delhi, India. Mobile No. - 9899900589 and 9582247600
